Enoxaparin Sodium Injection
Product Images NDC 25021-410

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 25021-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Eno0i 0000 01)

FDA Label Image

Figure (Eno0i 0000 02)

FDA Label Image

Figure (Eno0i 0000 03)

FDA Label Image

Figure (Eno0i 0000 04)

FDA Label Image

Figure (Eno0i 0000 05)

FDA Label Image

Figure (Eno0i 0000 06)

FDA Label Image

Figure (Eno0i 0000 07)

FDA Label Image

Figure (Eno0i 0000 08)

FDA Label Image

Figure (Eno0i 0000 09)

FDA Label Image

Figure (Eno0i 0000 10)

FDA Label Image

Figure (Eno0i 0000 11)

FDA Label Image

Figure (Eno0i 0000 12)

FDA Label Image

Figure (Eno0i 0000 13)

FDA Label Image

Figure (Eno0i 0000 14)

FDA Label Image

Figure (Eno0i 0000 15)

FDA Label Image

Figure (Eno0i 0000 16)

FDA Label Image

Figure (Eno0i 0000 17)

FDA Label Image

Figure (Eno0i 0000 18)

FDA Label Image

Figure (Eno0i 0000 19)

FDA Label Image

Figure (Eno0i 0000 20)

FDA Label Image

Figure (Eno0i 0000 21)

FDA Label Image

Figure (Eno0i 0000 22)

FDA Label Image

Figure (Eno0i 0000 23)

FDA Label Image

Figure (Eno0i 0000 24)

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 25)

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 26)

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 27)

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 28)

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 28)
This text contains information about a medication called Enoxaparin Sodium Injection, which contains 80 mg of enoxaparin. The medication is intended for subcutaneous injection and the dosage information and administration directions can be found in the insert. The text also includes a warning to keep the medication out of reach of children. However, due to the presence of errors and incomplete sentences, a more detailed description cannot be generated.*
FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 29)

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 29)
Enoxaparin Sodium Injection, USP is a medication used for subcutaneous injection. It is derived from porcine intestinal mucosa and is diluted in water for injection. The dosage information and directions for use can be found in the package insert. Each 0.025 mL graduation on the syringe equals 2.5 mg of enoxaparin sodium. It should be stored at a temperature between 20°C and 25°C (between 68°F and 77°F). It is important to keep this medication out of reach of children.*
FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 30)

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 31)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.